Q4 2020 Oasmia Pharmaceutical AB Earnings Call Transcript
Welcome to the Oasmia Pharmaceutical Q4 2020. With us today, we have François Martelet, [CEO] of the Board. (Operator Instructions) I will now hand over to your speakers. Please go ahead.
§ - ()-
Thank you very much, and welcome to everyone attending this call -- this quarterly report call that I will be pleased to go through right now.
So if you could move the presentation to Slide 3. So you will see that I will be doing this together with our CFO, Michael af Winklerfelt.
On Slide 4, you see that we will -- I will give you an overview of Oasmia. I will go through the quarterly events and forward results, and obviously, the key drivers from an outlook perspective, and then I will end this presentation before the Q&A with a summary of the presentation.
Now let's turn to Slide 5. So on this slide, that does show pretty well what we are, and I have to say that we are not a drug delivery company as one could think about. But we are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |